Evidence map›Paper›PMID 41155977›Full record

ReviewPharmaceutics2025

In Vitro Skin Models as Non-Animal Methods for Dermal Drug Development and Safety Assessment.

Viviana Stephanie Costa Gagosian, Raquel Coronel, Bruna Caroline Buss, Maria Luiza Ferreira Dos Santos, Isabel Liste, Berta Anta, Leonardo Foti

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Viviana Stephanie Costa GagosianGraduate Program in Bioscience and Biotechnology, Carlos Chagas Institute (ICC/FIOCRUZ-PR), Curitiba 81310-020, PR, Brazil.ORCID 0000-0002-9822-2642
Raquel CoronelUnidad de Regeneración Neural, Unidad Funcional de Investigación de Enfermedades Crónicas (UFIEC), Instituto de Salud Carlos III (ISCIII), 28220 Majadahonda, Madrid, Spain.ORCID 0000-0002-1156-2151
Bruna Caroline BussGraduate Program in Biological Sciences, Federal University of Paraná, Curitiba 80060-000, PR, Brazil.ORCID 0000-0002-6522-8984
Maria Luiza Ferreira Dos SantosGraduate Program in Bioscience and Biotechnology, Carlos Chagas Institute (ICC/FIOCRUZ-PR), Curitiba 81310-020, PR, Brazil.ORCID 0000-0002-6586-9714
Isabel ListeUnidad de Regeneración Neural, Unidad Funcional de Investigación de Enfermedades Crónicas (UFIEC), Instituto de Salud Carlos III (ISCIII), 28220 Majadahonda, Madrid, Spain.ORCID 0000-0002-3294-9558
Berta AntaUnidad de Biología Celular, Unidad Funcional de Investigación de Enfermedades Crónicas (UFIEC), Instituto de Salud Carlos III (ISCIII), 28220 Majadahonda, Madrid, Spain.ORCID 0000-0001-5972-5485
Leonardo FotiGraduate Program in Bioscience and Biotechnology, Carlos Chagas Institute (ICC/FIOCRUZ-PR), Curitiba 81310-020, PR, Brazil.ORCID 0000-0003-2948-9914

Funding

AESI 2020 initiative PI20CIII/00029Coordenação de Aperfeicoamento de Pessoal de Nível Superior 88881.934343/2024-01ERDF A Way of Making EuropeICC/FIOCRUZ PEP-ICC-008-FIO-21-2-36ICC/FIOCRUZ PEP-ICC-008-FIO-21-2-39INOVA Program-Innovative Ideas 2Instituto de Salud Carlos III PI22CIII/00055 and PI20CIII/00029MCIN/AEI/10.13039/501100011033 PID2021-126715OB-I00
6 · The paper itself

Abstract

Research on in vitro skin models has advanced remarkably, driven by a better understanding of the skin and the search for more ethical and efficient methods. The development of these models was initially motivated by the need for reduced animal testing and a faster and more ethical approach for the safety evaluation of cosmetic and pharmaceutical products. Stricter regulations and growing ethical awareness have driven further evolution, resulting in more refined and reliable methods. Diversity of cell types is crucial to replicating the complexity of human skin, including epithelial, dendritic, endothelial, and adipose cells, providing environments that closely mimic the physiological skin environment. This allows for more precise studies on skin interactions with cosmetic, dermatological, and pharmaceutical products. In vitro skin models have applications in toxicity testing, dermatological product evaluation, skin ageing studies, and drug research, reducing dependence on animal testing. This review presents a look at the different types of in vitro skin models developed for various applications, with a brief look at their strengths and drawbacks. Models developed for disease-specific applications are also covered. Techniques such as bioprinting and organ-on-a-chip have revolutionised the manufacturing of these models. Challenges persist, such as the need to improve vascularisation and faithfully replicate skin architecture. The promising future of these models points to an exciting path forward for dermatological research and the cosmetic industry. This review addresses the history and regulations of skin models, explores various skin models, and highlights the most recent advances, outlining future perspectives and offering a comprehensive overview.

Indexed as

new approach methodologies (NAMs)reconstructed human skin modelsregulationstissue engineeringtopical deliverytoxicologytransdermal delivery

Identifiers

PMID41155977
PMCPMC12567139

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.